Literature DB >> 25696038

Severe haemorrhage following intrapleural streptokinase therapy for haemothorax after myocardial revascularisation with the left internal mammary artery.

J B Winter, J G Zijlstra, T S van der Werf.   

Abstract

Administration of intrapleural streptokinase is a well-accepted therapy for the treatment of haemothorax following myocardial revascularisation with the inner mammary artery (IMA). The present report describes a patient who developed severe hypotension with an accompanying drop in haemoglobin concentration induced by the sixth consecutive instillation of intrapleural streptokinase. This case suggests that the standard streptokinase therapy of six to eight instillations might be too much for these patients.

Entities:  

Keywords:  CABG; haemothorax; streptokinase

Year:  2002        PMID: 25696038      PMCID: PMC2499785     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  9 in total

1.  Use of purified streptokinase in empyema and hemothorax.

Authors:  R W Aye; D P Froese; L D Hill
Journal:  Am J Surg       Date:  1991-05       Impact factor: 2.565

2.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

Authors:  W S Tillett; S Sherry
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

3.  Exclusive use of arterial grafts in coronary artery bypass operations for three-vessel disease: use of both thoracic arteries and the gastroepiploic artery in 256 consecutive patients.

Authors:  J G Grandjean; A A Voors; P W Boonstra; P den Heyer; T Ebels
Journal:  J Thorac Cardiovasc Surg       Date:  1996-10       Impact factor: 5.209

4.  Intrapleural streptokinase in the treatment of haemothorax and empyema.

Authors:  N P Bergh; R Ekroth; S Larsson; P Nagy
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1977

5.  [Treatment with intrapleural streptokinase for coagulated hemothorax after cardiac surgery with cardiopulmonary bypass].

Authors:  G Careaga; J Esparza; C Riera; A Ramírez-Castañeda; S Ramírez-Castañeda; R Argüero
Journal:  Rev Esp Cardiol       Date:  2001-03       Impact factor: 4.753

6.  The systemic fibrinolytic activity of intrapleural streptokinase.

Authors:  C W Davies; S Lok; R J Davies
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

7.  Major hemorrhage following administration of intrapleural streptokinase.

Authors:  P J Godley; R C Bell
Journal:  Chest       Date:  1984-09       Impact factor: 9.410

8.  Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.

Authors:  D Bouros; S Schiza; P Panagou; J Drositis; N Siafakas
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

9.  Intrapleural streptokinase in the management of empyema.

Authors:  R F Taylor; M B Rubens; M C Pearson; N C Barnes
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.